Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

Zhou, Jian; Sun, Hui‐Chuan; Wang, Zheng; Cong, Wen‐Ming; Wang, Jianhua; Zeng, Mengsu; Yang, Jia-Mei; Bie, Ping; Liu, Lian-xin; Wen, Tianfu; Han, Guo-Hong; Wang, Maoqiang; Liu, Rui-Bao; Lu, Ligong; Ren, Zheng-Gang; Chen, Min-Shan; Zeng, Zhao‐Chong; Liang, Ping; Liang, Changhong; Chen, Min; Yan, Fuhua; Wang, Wen-Ping; Ji, Yuan; Cheng, Wen-Wu; Dai, Chao-liu; Jia, Wei-Dong; Li, Ya-Ming; Li, Ye‐Xiong; Liang, Jun; Liu, Tian-Shu; Lv, Guoyue; Mao, Yi-Lei; Ren, Wei-Xin; Shi, Hong-Cheng; Wang, Wen-Tao; Wang, Xiaoying; Xing, Bao-Cai; Xu, Jian-Ming; Yang, Jian-Yong; Yang, Ye-Fa; Ye, Sheng-Long; Yin, Zheng-Yu; Zhang, Bo-Heng; Zhang, Shui-jun; Zhou, Wei-Ping; Zhu, Ji-Ye; Liu, Rong; Shi, Ying-Hong; Xiao, Yong-Sheng; Dai, Zhi; Teng, Gao‐Jun; Cai, Jian-qiang; Wang, Wei–Lin; Dong, Jiahong; Li, Qiang; Shen, Feng; Qin, Shu-Kui; Fan, Jia

doi:10.1159/000488035

Public

Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

Published in Liver Cancer • Jan 1, 2018

Authors:

Jian Zhou

Hui‐Chuan Sun

Zheng Wang

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) (about 85-90% of primary liver cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis B infection. HCC is the fourth most common malignancy and the third leading cause of tumor-related deaths in China. It poses a sign...

Subject

Medicine

Guideline

Hepatocellular carcinoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!